Sanuwave Health Inc. SNWV
5.04
0.19
3.92%
as of 25 Sep
- Market cap
- $41.7M
- P/E
- 3.0×
Follow SNWV
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
30.70% | (166.66%) | (213.43%) | (254.57%) | |
| (33.78%) | 35.02% | 48.54% | 43.82% | ||
ROIC |
25.73% | 26.60% | 17.31% | 7.46% | |
Return on Tangible Assets |
(192.10%) | 134.97% | 218.00% | 209.52% | |
Average Days of Receivables |
40.97 | 44.93 | 49.39 | 48.10 | |
Free Cash Flow per Share |
0.49 | 0.85 | 1.07 | 1.09 | |
Free Cash Flow |
4.22 | 7.31 | 9.23 | 9.37 | |
Capital Expenditures |
2.92 | 3.43 | 3.44 | 4.15 | |
Piotroski F-Score |
6.00 | 7.00 | 6.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
4.32% | 10.91% | 17.45% | 16.66% | |
Accounts Receivable Turnover |
11.04 | 10.07 | 8.99 | 9.12 | |
Accounts Payable Turnover |
2.21 | 2.89 | 2.76 | 2.85 | |
Inventory Turnover |
1.75 | 2.00 | 1.82 | 1.61 | |
Average Days of Payables |
162.35 | 117.70 | 117.51 | 115.86 | |
Days of Inventory on Hand |
277.12 | 214.83 | 208.94 | 247.63 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.19% | 3.07% | 4.07% | 5.09% | |
Selling, General and Administrative Expense of Revenue |
63.21% | 60.82% | 63.30% | 65.53% | |
Share Based Compensation of Revenue |
12.21% | 11.01% | 12.59% | 13.37% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.13) | 0.33 | 0.35 | 0.34 | |
Depreciation/Fixed assets |
1.68 | 1.39 | 1.21 | 0.84 | |
Capex/Depreciation |
0.87 | 1.25 | 1.49 | 2.20 | |
Revenue per Share |
4.80 | 5.14 | 5.16 | 5.12 | |
Operating CF per Share |
0.15 | 0.45 | 0.67 | 0.61 | |
Capex per Share |
0.34 | 0.40 | 0.40 | 0.48 | |
Capex to Sales |
(0.07) | (0.08) | (0.08) | (0.09) | |
Net Profit Margin |
(23.57%) | 26.82% | 37.20% | 34.66% |
Columns are period end dates